[1]
“Azithromycin and Hydroxychloroquine combination: The future pharmacotherapy of COVID-19”, J. Biomed. Sci., vol. 7, no. 2, pp. 54–57, Dec. 2020, doi: 10.3126/jbs.v7i2.33997.